Differences in the Progression from Mild Cognitive Impairment to Alzheimer's Disease between APOE4 Carriers and Non-Carriers

Antonio Martinez-Torteya, Alejandro I. Trejo-Castro, José M. Celaya-Padilla, Jose G. Tamez-Peña

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

An early diagnosis of Alzheimer's disease (AD) is important for both support and therapeutic planning. Predicting who will progress from mild cognitive impairment (MCI) to AD would yield the same clinical benefits. However, it has been shown that the MCI to AD progression varies depending on certain demographic characteristics. AD is highly associated with the apolipoprotein E type 4 allele expressing the protein isoform APOE4. This study aimed at identifying features associated with the MCI to AD progression whose temporal evolution significantly differs between APOE4 carriers and non-carriers. Longitudinal information from 336 subjects (64.58% carriers) who progressed from MCI to AD was gathered, including laboratory assays, information from MRI and PET analyses, and neuropsychological tests. Longitudinal models identified 11 features with significant differences in their behavior between carriers and non-carriers, demonstrating that the way in which carriers and non-carriers progress from MCI to AD is significantly different.
Original languageEnglish
Title of host publicationProceedings - 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering, BIBE 2019
PublisherInstitute of Electrical and Electronics Engineers (IEEE)
Pages199-203
Number of pages5
ISBN (Electronic)9781728146171
ISBN (Print)9781728146171
DOIs
Publication statusPublished - Oct 2019

Publication series

NameProceedings - 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering, BIBE 2019

All Science Journal Classification (ASJC) codes

  • Information Systems
  • Biomedical Engineering
  • Health Informatics

Fingerprint Dive into the research topics of 'Differences in the Progression from Mild Cognitive Impairment to Alzheimer's Disease between APOE4 Carriers and Non-Carriers'. Together they form a unique fingerprint.

  • Cite this

    Martinez-Torteya, A., Trejo-Castro, A. I., Celaya-Padilla, J. M., & Tamez-Peña, J. G. (2019). Differences in the Progression from Mild Cognitive Impairment to Alzheimer's Disease between APOE4 Carriers and Non-Carriers. In Proceedings - 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering, BIBE 2019 (pp. 199-203). [8941924] (Proceedings - 2019 IEEE 19th International Conference on Bioinformatics and Bioengineering, BIBE 2019). Institute of Electrical and Electronics Engineers (IEEE). https://doi.org/10.1109/bibe.2019.00043